Biological E

Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.

The permission has been given to Biological E after the recommendation from the Subject Expert Committee.

Biological E's made-in-India vaccine is expected to have 90 per cent effectiveness against Covid and will likely be a gamechanger in the fight against the pandemic, says a top doctor on a government advisory panel.

Hyderabad-based Biological E said on Tuesday it has entered into a licensing agreement with Providence Therapeutics Holdings to manufacture the Canadian company's mRNA COVID-19 vaccine in India.

J&J's COVID-19 vaccine, to be manufactured in India by Biological E, will have to be handed over entirely to the US pharma giant as agreed but the government is looking at the possibility of securing a part of this production, sources said.

The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization (SRA) and/or WHO Emergency Use listing including Johnson & Johnson vaccines.

Pharmaceutical companies Bharat Biotech and Biological E Ltd said on Monday they could quickly rework their COVID-19 vaccine products to fight new variants once their genetic sequence is known. In recent months, India has confirmed the presence of the variants first identified in Brazil, Britain and South Africa, which are believed to explain an up...

Pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.

64 ambassadors and high commissioners of various countries visited two key biotech companies in Hyderabad that are developing vaccines against coronavirus. The envoys first stopped at Hyderabad-based Bharat Biotech and next at Biological E.

Prime Minister Narendra Modi will interact with three teams involved in developing COVID-19 vaccines via video conferencing on Monday. The Prime Minister's Office tweeted today that the three teams are from Gennova Biopharma, Biological E and Dr Reddy's.

Biological E. Ltd has started human trials of its COVID-19 vaccine candidate and expects results by February, the drugmaker said on Monday.

In the race to find a cure for the coronavirus infection, Texas-based Baylor College of Medicine (BCM) has entered into a licensing agreement with Indian pharmaceutical company Biological E Limited (BE) for the development of a safe, effective and affordable vaccine.

Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.

The permission has been given to Biological E after the recommendation from the Subject Expert Committee.

Biological E's made-in-India vaccine is expected to have 90 per cent effectiveness against Covid and will likely be a gamechanger in the fight against the pandemic, says a top doctor on a government advisory panel.

Hyderabad-based Biological E said on Tuesday it has entered into a licensing agreement with Providence Therapeutics Holdings to manufacture the Canadian company's mRNA COVID-19 vaccine in India.

J&J's COVID-19 vaccine, to be manufactured in India by Biological E, will have to be handed over entirely to the US pharma giant as agreed but the government is looking at the possibility of securing a part of this production, sources said.

The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization (SRA) and/or WHO Emergency Use listing including Johnson & Johnson vaccines.

Pharmaceutical companies Bharat Biotech and Biological E Ltd said on Monday they could quickly rework their COVID-19 vaccine products to fight new variants once their genetic sequence is known. In recent months, India has confirmed the presence of the variants first identified in Brazil, Britain and South Africa, which are believed to explain an up...

Pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.

64 ambassadors and high commissioners of various countries visited two key biotech companies in Hyderabad that are developing vaccines against coronavirus. The envoys first stopped at Hyderabad-based Bharat Biotech and next at Biological E.

Prime Minister Narendra Modi will interact with three teams involved in developing COVID-19 vaccines via video conferencing on Monday. The Prime Minister's Office tweeted today that the three teams are from Gennova Biopharma, Biological E and Dr Reddy's.

Biological E. Ltd has started human trials of its COVID-19 vaccine candidate and expects results by February, the drugmaker said on Monday.

In the race to find a cure for the coronavirus infection, Texas-based Baylor College of Medicine (BCM) has entered into a licensing agreement with Indian pharmaceutical company Biological E Limited (BE) for the development of a safe, effective and affordable vaccine.